1 Introduction
1.1 What Is This Report About?
1.2 Aortic Stent Grafts Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Aortic Stent Grafts Market, United States
2.1 Aortic Stent Grafts Market, United States, Revenue ($m), 2024-2036
2.1.1 Extension Pieces Market, United States, Revenue ($m), by Segment, 2024-2036
2.2 Aortic Stent Grafts Market, United States, Volume (Units), 2024-2036
2.2.1 Extension Pieces Market, United States, Volume (Units), by Segment, 2024-2036
2.3 Aortic Stent Grafts Market, United States, Average Price ($), 2024-2036
2.4 Aortic Stent Grafts Market, United States, Company Share by Revenue ($m), 2025
3 Aortic Stent Grafts Market Pipeline Products
3.1 Aortic Stent Grafts Market Pipeline Products
3.2 Aortic Stent Grafts - Pipeline Products by Stage of Development
3.3 Aortic Stent Grafts - Pipeline Products by Segment
3.4 Aortic Stent Grafts - Pipeline Products by Territory
3.5 Aortic Stent Grafts - Pipeline Products by Regulatory Path
3.6 Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in United States, Aortic Stent Grafts Market
4.1 W. L. Gore & Associates Inc
4.1.1 Company Overview
4.2 Cook Medical LLC
4.2.1 Company Overview
4.3 Medtronic Plc
4.3.1 Company Overview
4.4 Endologix LLC
4.4.1 Company Overview
4.5 Terumo Corp
4.5.1 Company Overview
4.6 Artivion Inc
4.6.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
5.1.2 Nov 04, 2025: Thoraflex Hybrid Graft Insertion In A Patient With Marfan Syndrome
5.1.3 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
5.1.4 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
5.1.5 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
5.1.6 Oct 09, 2025: Abbott And Abbott Fund Support Northern Illinois Food Bank With $250,000 Grant To Address Childhood Hunger
5.1.7 Sep 24, 2025: CWSL Alumna Sherry S. Bahrambeygui Elected to UC San Diego Foundation Board
5.1.8 Sep 08, 2025: UC San Diego Foundation Announces New Trustees
5.1.9 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
5.1.10 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
5.2 Financial Announcements
5.2.1 Apr 02, 2026: Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
5.2.2 Feb 24, 2026: Merit Medical Reports Fourth Quarter and Full-Year 2025 Results, Provides Fiscal 2026 Guidance
5.2.3 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
5.2.4 Jan 05, 2026: Abbott Hosts Conference Call for Fourth-Quarter Earnings
5.2.5 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
5.2.6 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
5.2.7 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
5.2.8 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
5.2.9 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
5.3 Government and Public Interest
5.3.1 Feb 27, 2026: LeMaitre to Participate at Upcoming Investor Conferences in March
5.3.2 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
5.3.3 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
5.4 Legal And Regulatory
5.4.1 Jan 06, 2026: Butterfly Network to Extend its Proprietary 3D Imaging Capabilities to Butterfly Garden Developers
5.4.2 Jun 03, 2025: Site Activation and First Patient Consent in Australia for Phase 3 Knee OA Study
5.5 Other Significant Developments
5.5.1 Nov 25, 2025: Redo Frozen Elephant Trunk After Endovascular Arch Repair
5.5.2 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
5.5.3 Nov 04, 2025: Vir Biotechnology concludes Eclipse 1 Phase III trial enrolment for CHD
5.5.4 Oct 16, 2025: Shape Memory Medical Reaches Midway Milestone in AAA-SHAPE Trial
5.5.5 Oct 03, 2025: RTI Develops Wearable Data Platform to Support Precision Health Monitoring for Military Personnel
5.6 Product News
5.6.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
5.6.2 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
5.6.3 Nov 12, 2025: VitAA Medical Receives FDA Clearance for AiORTA Plan in Aortic Care
5.6.4 Nov 06, 2025: Artivion Treats First Patient in ARTIZEN Trial for Arcevo LSA
5.6.5 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
5.6.6 Nov 05, 2025: Fluid Control Solutions For MedTech
5.6.7 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
5.6.8 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
5.6.9 Oct 16, 2025: Shape Memory Medical Reaches Midway Milestone in AAA-SHAPE Trial
5.6.10 Oct 13, 2025: Getinge’s Advanta V12 Receives CE Mark for Major Bridging Indications
5.6.11 Oct 01, 2025: Bentley and Terumo Aortic Collaborate on Clinical Study for FEVAR Procedures
5.7 Strategy And Business Planning
5.7.1 Apr 01, 2026: Tempus and Medtronic Announce Alert Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
5.7.2 Jan 09, 2026: Major Medical Devices Secures Funding to Advance Novel AAA Repair Device
5.7.3 Oct 01, 2025: Bentley and Terumo Aortic Collaborate on Clinical Study for FEVAR Procedures
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer
List of Tables
Table 1: Aortic Stent Grafts Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 2: Extension Pieces Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 3: Aortic Stent Grafts Market, United States, Volume (Units), 2024-2036
Table 4: Extension Pieces Market, United States, Volume (Units), 2024-2036
Table 5: Aortic Stent Grafts Market, United States, Average Price ($), 2024-2036
Table 6: Aortic Stent Grafts Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 7: Aortic Stent Grafts Market Pipeline Products
Table 8: Aortic Stent Grafts - Pipeline Products by Stage of Development
Table 9: Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
Table 10: Aortic Stent Grafts - Pipeline Products by Segment
Table 11: Aortic Stent Grafts - Pipeline Products by Territory
Table 12: Aortic Stent Grafts - Pipeline Products by Regulatory Path
Table 13: Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
Table 14: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Aortic Stent Grafts Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 2: Extension Pieces Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 3: Aortic Stent Grafts Market, United States, Volume (Units), 2024-2036
Figure 4: Extension Pieces Market, United States, Volume (Units), 2024-2036
Figure 5: Aortic Stent Grafts Market, United States, Company Share (%), 2025
Figure 6: Aortic Stent Grafts - Pipeline Products by Stage of Development
Figure 7: Aortic Stent Grafts - Pipeline Products by Segment
Figure 8: Aortic Stent Grafts - Pipeline Products by Territory
Figure 9: Aortic Stent Grafts - Pipeline Products by Regulatory Path
Figure 10: Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
